Hong Kong

2 Vaccines Approved for Use in Hong Kong

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: reuters.com

5 in Clinical Trials in Hong Kong

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
DNA

The University of Hong Kong

SARS-CoV-2 DNA Vaccine

Replicating Viral Vector

The University of Hong Kong

DelNS1-nCoV-RBD LAIV